These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 33200813)

  • 1. Effects of trimetazidine in patients with severe chronic heart failure with reduced left ventricular ejection fraction: A prospective, randomized, open-label, cross-over study.
    Bohdan M; Stopczyńska I; Wiśniewski P; Moryś J; Niedoszytko P; Gruchała M
    Cardiol J; 2022; 29(4):627-636. PubMed ID: 33200813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of trimetazidine in nonischemic heart failure: a randomized study.
    Winter JL; Castro PF; Quintana JC; Altamirano R; Enriquez A; Verdejo HE; Jalil JE; Mellado R; Concepción R; Sepúlveda P; Rossel V; Sepúlveda L; Chiong M; García L; Lavandero S
    J Card Fail; 2014 Mar; 20(3):149-54. PubMed ID: 24412523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trimetazidine improves left ventricular global longitudinal strain value in patients with heart failure with reduced ejection fraction due to ischemic heart disease.
    Harjoko RP; Sobirin MA; Uddin I; Bahrudin U; Maharani N; Herminingsih S; Tsutsui H
    Drug Discov Ther; 2022 Sep; 16(4):177-184. PubMed ID: 36002315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trimetazidine and reduction in mortality and hospitalization in patients with ischemic dilated cardiomyopathy: a post hoc analysis of the Villa Pini d'Abruzzo Trimetazidine Trial.
    Di Napoli P; Di Giovanni P; Gaeta MA; Taccardi AA; Barsotti A
    J Cardiovasc Pharmacol; 2007 Nov; 50(5):585-9. PubMed ID: 18030070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy of trimetazidine in non-ischemic heart failure patients: a meta-analysis of randomized controlled trials.
    Zhao C; Jin C; He X; Xiang M
    Rev Cardiovasc Med; 2021 Dec; 22(4):1451-1459. PubMed ID: 34957784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trimetazidine potentiates the effects of exercise training in patients with ischemic cardiomyopathy referred for cardiac rehabilitation.
    Belardinelli R; Lacalaprice F; Faccenda E; Volpe L
    Eur J Cardiovasc Prev Rehabil; 2008 Oct; 15(5):533-40. PubMed ID: 18797405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The acute administration of trimetazidine modified myocardial perfusion and left ventricular function in 31 patients with ischaemic ventricular dysfunction.
    Feola M; Biggi A; Francini A; Leonardi G; Ribichini F; Ferrero V; Uslenghi E
    Int J Cardiovasc Imaging; 2004 Aug; 20(4):315-20. PubMed ID: 15529915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved left and right ventricular functions with trimetazidine in patients with heart failure: a tissue Doppler study.
    Gunes Y; Guntekin U; Tuncer M; Sahin M
    Heart Vessels; 2009 Jul; 24(4):277-82. PubMed ID: 19626400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of trimetazidine on heart failure with reduced ejection fraction and associated clinical outcomes: a systematic review and meta-analysis.
    Nassiri S; Van de Bovenkamp AA; Remmelzwaal S; Sorea O; de Man F; Handoko ML
    Open Heart; 2024 May; 11(1):. PubMed ID: 38719498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Qishen Taohong Granule () as Adjuvant Therapy for Improving Cardiac Function and Quality of Life in Patients with Chronic Heart Failure: A Randomized Controlled Trial.
    Li XX; Wu Y; Fan ZJ; Cui J; Li D; Lin Q; Zhuang R; Yan RK; Lin Q; Li Y
    Chin J Integr Med; 2022 Jan; 28(1):12-19. PubMed ID: 34387827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is treatment with trimetazidine beneficial in patients with chronic heart failure?
    Zhou X; Chen J
    PLoS One; 2014; 9(5):e94660. PubMed ID: 24797235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Trimetazidine in correction of chronic heart failure in patients with ischemic heart disease].
    Nedoshivin AO; Kutuzova AE; Nesterova IV; Mikhaĭlova IE; Rubashkina EI; Novikova NA; Liasnikova EA; Perepech NB
    Kardiologiia; 2002; 42(3):12-5. PubMed ID: 12494179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of metabolic modulation by trimetazidine on left ventricular function and phosphocreatine/adenosine triphosphate ratio in patients with heart failure.
    Fragasso G; Perseghin G; De Cobelli F; Esposito A; Palloshi A; Lattuada G; Scifo P; Calori G; Del Maschio A; Margonato A
    Eur Heart J; 2006 Apr; 27(8):942-8. PubMed ID: 16510466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Implications of Functional Mitral Regurgitation Severity in Patients with Heart Failure with Reduced Ejection Fraction (HFrEF).
    Naser N
    Med Arch; 2022 Feb; 76(1):17-22. PubMed ID: 35422569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of trimetazidine on left ventricular systolic function and physical tolerance in patients with ischaemic cardiomyopathy.
    Sisakian H; Torgomyan A; Barkhudaryan A
    Acta Cardiol; 2007 Oct; 62(5):493-9. PubMed ID: 17982971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of trimetazidine on heart rate variability in patients with heart failure.
    Gunes Y; Guntekin U; Tuncer M; Sahin M
    Arq Bras Cardiol; 2009 Aug; 93(2):154-8. PubMed ID: 19838493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized clinical trial of trimetazidine, a partial free fatty acid oxidation inhibitor, in patients with heart failure.
    Fragasso G; Palloshi A; Puccetti P; Silipigni C; Rossodivita A; Pala M; Calori G; Alfieri O; Margonato A
    J Am Coll Cardiol; 2006 Sep; 48(5):992-8. PubMed ID: 16949492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exercise-based cardiac rehabilitation in patients with reduced left ventricular ejection fraction: The Cardiac Rehabilitation Outcome Study in Heart Failure (CROS-HF): A systematic review and meta-analysis.
    Bjarnason-Wehrens B; Nebel R; Jensen K; Hackbusch M; Grilli M; Gielen S; Schwaab B; Rauch B;
    Eur J Prev Cardiol; 2020 Jun; 27(9):929-952. PubMed ID: 31177833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of ivabradine on the cardiac function of chronic heart failure reduced ejection fraction: Meta-analysis of randomized controlled trials.
    Bryan Richard S; Huang B; Liu G; Yang Y; Luo S
    Clin Cardiol; 2021 Apr; 44(4):463-471. PubMed ID: 33638556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heart Failure and Midrange Ejection Fraction: Implications of Recovered Ejection Fraction for Exercise Tolerance and Outcomes.
    Nadruz W; West E; Santos M; Skali H; Groarke JD; Forman DE; Shah AM
    Circ Heart Fail; 2016 Apr; 9(4):e002826. PubMed ID: 27009553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.